Clinical trials
Phase 2 Hypertension, Pulmonary trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 7 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Actelion | 2 |
| Montreal Heart Institute | 2 |
| University of Alberta | 2 |
| Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 1 |
| AllRock Bio, Inc. | 1 |
| Altavant Sciences GmbH | 1 |
| Andre Denault | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Bellerophon Pulse Technologies | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 19 |
| Pulmonary Arterial Hypertension | 5 |
| Heart Failure | 2 |
| Hypertension | 2 |
| Lung Diseases, Interstitial | 2 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
| Fibrosis | 1 |
| Hereditary Sensory and Autonomic Neuropathies | 1 |
| Lung Diseases | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.